Process-Engineering Mechanics of High-Dilution Intermediate Trituration Matrices for Microgram-Scale Actives

The principal process-engineering risk in a low-inclusion micronutrient corrector is the mass imbalance between its smallest actives and its bulk. Several actives in a 5 g unit — vitamin D₃, vitamin B₁₂, selenium, iodine, folate — are present at microgram scale, yet must be distributed uniformly through a matrix composed largely of calcium salts and a food-form palatant. Weighing such actives neat into a bulk mixer invites gravity segregation and particle-size mismatch, producing hot spots and voids across sequential packing runs. This paper describes the mitigation: a multi-stage geometric trituration ladder of at least fifty-fold per dilution stage, in decades as the neat mass requires, onto a shared inert carrier pool in an isolated compounding stream before the intermediate enters the bulk blend. It sets out a four-view bill-of-materials standard that keeps raw weighed material, process requirement, acceptance criterion and measured result in separate columns so that a design target is never mistaken for an analytical result — and it states plainly that the measured column is pending the production performance-qualification phase at the date of this record. It also documents why the food-form palatant is treated as a characterised nutritional input rather than an inert carrier, and why that characterisation had to be made by the authors: commercial palatants are proprietary formulations whose suppliers do not disclose nutrient composition, so a validation programme waiting on such a disclosure would wait indefinitely. Finally it reports in-pack stability, which is where the paper's quantitative result sits. A single blended unit has no compartments, so protection for labile actives is particle-level and environmental rather than locational, and rests on four shared controls. Because the potency ceiling of vitamins A and D₃ is a toxicity limit, their decay must be addressed by form, never by adding more. Modelling twelve months of decay against literature retention factors, both adult corrections clear the acceptance criterion at expiry as well as at manufacture: at 100,000 draws per species, the feline Wilson-95 lower bound is at or above 99.973% at manufacture and 99.983% at twelve months, and the canine at or above 99.972% and 99.950%. Differences of that size are run-to-run variation rather than a decay effect in either direction, and the correct reading is that twelve months of modelled decay does not move the gate. The reason is structural: the binding nutrient is copper, a mineral that does not decay, which accounts for the majority of the residual failing tail in both species, while the labile vitamins sit far enough above their floors that a 5 to 12% loss does not bring them near. Decay's only signature is compositional — riboflavin's share of that (already negligible) tail grows. That overlay was run on the release-A-1.0.0 formulation at the species reference animals only; requirements throughout are the NRC recommended allowances [6].